Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;190(1):81-91.
doi: 10.1016/j.jsb.2014.10.007. Epub 2014 Oct 25.

The leucine-rich amelogenin protein (LRAP) is primarily monomeric and unstructured in physiological solution

Affiliations

The leucine-rich amelogenin protein (LRAP) is primarily monomeric and unstructured in physiological solution

Barbara J Tarasevich et al. J Struct Biol. 2015 Apr.

Abstract

Amelogenin proteins are critical to the formation of enamel in teeth and may have roles in controlling growth and regulating microstructures of the intricately woven hydroxyapatite (HAP). Leucine-rich amelogenin protein (LRAP) is a 59-residue splice variant of amelogenin and contains the N- and C-terminal charged regions of the full-length protein thought to control crystal growth. Although the quaternary structure of full-length amelogenin in solution has been well studied and can consist of self-assemblies of monomers called nanospheres, there is limited information on the quaternary structure of LRAP. Here, sedimentation velocity analytical ultracentrifugation (SV) and small angle neutron scattering (SANS) were used to study the tertiary and quaternary structure of LRAP at various pH values, ionic strengths, and concentrations. We found that the monomer is the dominant species of phosphorylated LRAP (LRAP(+P)) over a range of solution conditions (pH 2.7-4.1, pH 4.5-8, 50 mmol/L(mM) to 200 mM NaCl, 0.065-2 mg/mL). The monomer is also the dominant species for unphosphorylated LRAP (LRAP(-P)) at pH 7.4 and for LRAP(+P) in the presence of 2.5 mM calcium at pH 7.4. LRAP aggregates in a narrow pH range near the isoelectric point of pH 4.1. SV and SANS show that the LRAP monomer has a radius of ∼2.0 nm and an asymmetric structure, and solution NMR studies indicate that the monomer is largely unstructured. This work provides new insights into the secondary, tertiary, and quaternary structure of LRAP in solution and provides evidence that the monomeric species may be an important functional form of some amelogenins.

Keywords: Amelogenin; Biomineralization; Enamel; LRAP; Nanosphere.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Primary amino acid sequence of murine amelogenin with the basic and acidic residues colored blue and red, respectively. The splice variant LRAP is composed of the N-terminal 33 and C-terminal 26 residues, shaded yellow. Both full-length amelogenin and LRAP are post-translationally modified by side chain phosphorylation of S16, colored green. The serine at position 16 was either phosphorylated (LRAP(+P)) or non-phosphorylated (LRAP(−P)).
Figure 2
Figure 2
Zeta potential of LRAP (+P) in SCP solution at 50 and 150 mM NaCl as a function of pH. Data points are connected by smoothed lines.
Figure 3
Figure 3
Normalized sedimentation coefficient distribution for LRAP(+P) in 150 mM NaCl, pH 7.4 SCP solution at 2 mg/mL with a 400x expansion in the inset. Peaks are labeled with % amount and sedimentation coefficient, s20,w, value in svedbergs (S). The main peak was determined to represent a monomer and the s20,w value of the monomer peak is the average over the peak.
Figure 4
Figure 4
a) Rh for LRAP(+P) species in 0.065 mg/ml 50 mM NaCl SCP solutions including Rh of monomers determined by SV (open blue circles) and Rh of aggregates at pH 4.2 determined by DLS (filled blue circle), b) SV-determined f/f0 ratios for monomers in 0.065 mg/mL LRAP solutions including LRAP(+P) in 50 mM NaCl SCP (blue circles), LRAP(+P) in 150 mM NaCl SCP at pH 7.4 (green square), LRAP(−P) in 150 mM NaCl SCP at pH 7.4 (red triangle), and LRAP(+P) in 2.5 mM CaCl2 at pH 7.4 (orange diamond).
Figure 5
Figure 5
SANS I(q) vs. q data for a) 1 mg/mL LRAP(+P) in 2% acetic acid (pH 2.7) (black) and 150 mM NaCl, SCP (pH 7.4) (red) and b) 2 mg/mL (blue) and 1 mg/mL (black) LRAP(+P) in 2% acetic acid (pH 2.7) with the 2 mg/mL data normalized to the 1 mg/mL data to allow better comparison of the curves.
Figure 6
Figure 6
a) The SANS data from 2 mg/mL LRAP(+P) in 2% acetic acid (pH 2.7) along with the corresponding average (red) and best-fit (blue) model trace from the SASSIE calculations. The best-fit (blue) LRAP(+P) structure is shown under the traces. b) A χ2 versus Rg plot for the ensemble of 9427 SASSIE structures derived from the SANS data for 2 mg/mL LRAP(+P) in 2% acetic acid (pH 2.7). The corresponding points for the 10 lowest energy Rosetta model structures are shown in red. The best-fit (black) SASSIE structure and best-fit (red) lowest energy Rosetta structure are superimposed above the traces.
Figure 7
Figure 7
Analysis of the observed 13Cα and 13Cβ chemical shift deviations from random coil values for LRAP(−P) in 150 mM NaCl, SCP solution, pH 7.4 where Δδ13C = δRandom coilObserved. Red = 13Cα, cyan = 13Cβ. Asterisks indicate residues where it was not possible to obtain unambiguous 13Cβ assignments. The dashed purple line separated the residues present in the N- and C-terminal ends of full-length murine amelogenin. Random coil values obtained from cns_solve_1.1.

Similar articles

Cited by

References

    1. Amin HD, Olsen I, Knowles JC, Donos N. Differential Effect of Amelogenin Peptides on Osteogenic Differentiation In Vitro: Identification of Possible New Drugs for Bone Repair and Regeneration. Tissue Eng Part A. 2012;18:1193–1202. - PubMed
    1. Boabaid F, Gibson CW, Kuehl MA, Berry JE, Snead ML, Nociti FHJ, Katchburian E, Somerman MJ. Leucine-rich amelogenin peptide: a candidate signaling molecule during cementogenesis. J Periodontol. 2004;75:1126–36. - PubMed
    1. Bromley KM, Kiss AS, Lokappa SB, Lakshminarayanan R, Fan D, Ndao M, Evans JS, Moradian-Oldak J. Dissecting amelogenin protein nanospheres: characterization of metastable oligomers. J Biol Chem. 2011;286:34643–34653. - PMC - PubMed
    1. Buchko GW, Tarasevich BJ, Bekhazi J, Snead ML, Shaw WJ. A Solution NMR Investigation into the Early Events of Amelogenin Nanosphere Self-Assembly Initiated with Sodium Chloride or Calcium Chloride †. Biochemistry. 2008;47:13215–13222. - PMC - PubMed
    1. Buchko GW, Tarasevich BJ, Roberts J, Snead ML, Shaw WJ. A solution NMR investigation into the murine amelogenin splice-variant LRAP (Leucine-Rich Amelogenin Protein) Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics. 2010;1804:1768–1774. - PMC - PubMed

Publication types

LinkOut - more resources